Terms: = Thyroid cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Treatment
19 results:
1. The Usefulness of Elastin Staining to Detect Vascular Invasion in cancer.
Gonzalez J; Bahmad HF; Ocejo S; Abreu A; Popp M; Gogola S; Fernandez V; Recine M; Poppiti R
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894944
[TBL] [Abstract] [Full Text] [Related]
2. thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production.
Allison DB; Rueckert J; Cornea V; Lee CY; Dueber J; Bocklage T
Endocr Pathol; 2022 Jun; 33(2):315-326. PubMed ID: 34997561
[TBL] [Abstract] [Full Text] [Related]
3. Propofol Inhibits thyroid cancer Cell Proliferation, Migration, and Invasion by Suppressing SHH and PI3K/AKT Signaling Pathways via the miR-141-3p/brd4 Axis.
Zhang H; Tan M; Zhang J; Han X; Ma Y
J Healthc Eng; 2021; 2021():2704753. PubMed ID: 34956562
[TBL] [Abstract] [Full Text] [Related]
4. capsaicin restores sodium iodine symporter-mediated radioiodine uptake through bypassing canonical TSH‒TSHR pathway in anaplastic thyroid carcinoma cells.
Xu S; Cheng X; Wu J; Wang Y; Wang X; Wu L; Yu H; Bao J; Zhang L
J Mol Cell Biol; 2022 Jan; 13(11):791-807. PubMed ID: 34751390
[TBL] [Abstract] [Full Text] [Related]
5. brd4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination.
Jung H; Chen J; Hu X; Sun H; Wu SY; Chiang CM; Kemper B; Chen LF; Kemper JK
JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290278
[TBL] [Abstract] [Full Text] [Related]
6. capsaicin induces mitochondrial dysfunction and apoptosis in anaplastic thyroid carcinoma cells via TRPV1-mediated mitochondrial calcium overload.
Xu S; Cheng X; Wu L; Zheng J; Wang X; Wu J; Yu H; Bao J; Zhang L
Cell Signal; 2020 Nov; 75():109733. PubMed ID: 32771398
[TBL] [Abstract] [Full Text] [Related]
7. Potentiated anti-tumor effects of BETi by MEKi in anaplastic thyroid cancer.
Zhu X; Park S; Lee WK; Cheng SY
Endocr Relat Cancer; 2019 Sep; 26(9):739-750. PubMed ID: 31272080
[TBL] [Abstract] [Full Text] [Related]
8. Cold Atmospheric Plasma Induces HMGB1 Expression in cancer Cells.
Yoon Y; Ku B; Lee K; Jung YJ; Baek SJ
Anticancer Res; 2019 May; 39(5):2405-2413. PubMed ID: 31092433
[TBL] [Abstract] [Full Text] [Related]
9. Long non‑coding RNA UCA1 promotes papillary thyroid cancer cell proliferation via miR‑204‑mediated brd4 activation.
Li D; Cui C; Chen J; Hu Z; Wang Y; Hu D
Mol Med Rep; 2018 Sep; 18(3):3059-3067. PubMed ID: 30015945
[TBL] [Abstract] [Full Text] [Related]
10. AZD5153, a novel brd4 inhibitor, suppresses human thyroid carcinoma cell growth in vitro and in vivo.
Xu K; Chen D; Qian D; Zhang S; Zhang Y; Guo S; Ma Z; Wang S
Biochem Biophys Res Commun; 2018 May; 499(3):531-537. PubMed ID: 29596834
[TBL] [Abstract] [Full Text] [Related]
11. capsaicin inhibits the metastasis of human papillary thyroid carcinoma BCPAP cells through the modulation of the TRPV1 channel.
Xu S; Zhang L; Cheng X; Yu H; Bao J; Lu R
Food Funct; 2018 Jan; 9(1):344-354. PubMed ID: 29185571
[TBL] [Abstract] [Full Text] [Related]
12. Pharmacoepidemiology of Clinically Relevant Hypothyroidism and Hypertension from Sunitinib and Sorafenib.
Walko CM; Aubert RE; La-Beck NM; Clore G; Herrera V; Kourlas H; Epstein RS; McLeod HL
Oncologist; 2017 Feb; 22(2):208-212. PubMed ID: 28167571
[TBL] [Abstract] [Full Text] [Related]
13. MCM5 as a target of BET inhibitors in thyroid cancer cells.
Mio C; Lavarone E; Conzatti K; Baldan F; Toffoletto B; Puppin C; Filetti S; Durante C; Russo D; Orlacchio A; Di Cristofano A; Di Loreto C; Damante G
Endocr Relat Cancer; 2016 Apr; 23(4):335-47. PubMed ID: 26911376
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of brd4 suppresses tumor growth and enhances iodine uptake in thyroid cancer.
Gao X; Wu X; Zhang X; Hua W; Zhang Y; Maimaiti Y; Gao Z; Zhang Y
Biochem Biophys Res Commun; 2016 Jan; 469(3):679-85. PubMed ID: 26707881
[TBL] [Abstract] [Full Text] [Related]
15. Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiation.
Jang S; Yu XM; Odorico S; Clark M; Jaskula-Sztul R; Schienebeck CM; Kupcho KR; Harrison AD; Winston-McPherson GN; Tang W; Chen H
Cancer Gene Ther; 2015 Aug; 22(8):410-6. PubMed ID: 26251030
[TBL] [Abstract] [Full Text] [Related]
16. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
Boussemart L; Malka-Mahieu H; Girault I; Allard D; Hemmingsson O; Tomasic G; Thomas M; Basmadjian C; Ribeiro N; Thuaud F; Mateus C; Routier E; Kamsu-Kom N; Agoussi S; Eggermont AM; Désaubry L; Robert C; Vagner S
Nature; 2014 Sep; 513(7516):105-9. PubMed ID: 25079330
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial.
Lazarevic B; Boezelijn G; Diep LM; Kvernrod K; Ogren O; Ramberg H; Moen A; Wessel N; Berg RE; Egge-Jacobsen W; Hammarstrom C; Svindland A; Kucuk O; Saatcioglu F; Taskèn KA; Karlsen SJ
Nutr Cancer; 2011; 63(6):889-98. PubMed ID: 21714686
[TBL] [Abstract] [Full Text] [Related]
18. Antigen-specific IgG elicited in subjects with prostate cancer treated with flt3 ligand.
Dunphy EJ; McNeel DG
J Immunother; 2005; 28(3):268-75. PubMed ID: 15838384
[TBL] [Abstract] [Full Text] [Related]
19. Impact of parathyroid status and Ca and vitamin-D supplementation on bone mass and muscle-bone relationships in 208 Belarussian children after thyroidectomy because of thyroid carcinoma.
Schneider P; Biko J; Reiners C; Demidchik YE; Drozd VM; Capozza RF; Cointry GR; Ferretti JL
Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):444-50. PubMed ID: 15372365
[TBL] [Abstract] [Full Text] [Related]
